(Q44137633)

English

Pre- and post-exposure protection against Western equine encephalitis virus after single inoculation with adenovirus vector expressing interferon alpha

scientific article published on 29 August 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 November 2017

Pre- and post-exposure protection against Western equine encephalitis virus after single inoculation with adenovirus vector expressing interferon alpha (English)

1 reference

Europe PubMed Central

30 November 2017

vector-borne disease

0 references

1 reference

based on heuristic

inferred from title

Western equine encephalitis

1 reference

based on heuristic

inferred from title

equine encephalitis

1 reference

based on heuristic

inferred from title

Western equine encephalitis virus

object named as

Western equine encephalitis virus

1 reference

based on heuristic

inferred from title

author name string

Josh Q H Wu

1

1 reference

Europe PubMed Central

30 November 2017

Nicole D Barabé

2

1 reference

Europe PubMed Central

30 November 2017

Ying-Min Huang

3

1 reference

Europe PubMed Central

30 November 2017

George A Rayner

4

1 reference

Europe PubMed Central

30 November 2017

Mary E Christopher

5

1 reference

Europe PubMed Central

30 November 2017

Fay L Schmaltz

6

1 reference

Europe PubMed Central

30 November 2017

language of work or name

0 references

publication date

29 August 2007

1 reference

Europe PubMed Central

30 November 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

30 November 2017

369

1 reference

Europe PubMed Central

30 November 2017

1

1 reference

Europe PubMed Central

30 November 2017

206-213

1 reference

Europe PubMed Central

30 November 2017

Capsid Protein of Eastern Equine Encephalitis Virus Inhibits Host Cell Gene Expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Antibodies for defense against biological attack.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Recombinant adenovirus: a gene transfer vector for study and treatment of CNS diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Interferon-alpha2b secretion by adenovirus-mediated gene delivery in rat, rabbit, and chimpanzee results in similar pharmacokinetic profiles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Type 1 interferons and the virus-host relationship: a lesson in détente .

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Arbovirus infections of laboratory workers. Extent of problem emphasizes the need for more effective measures to reduce hazards

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

A humanized murine monoclonal antibody protects mice either before or after challenge with virulent Venezuelan equine encephalomyelitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Chimpanzee adenovirus vaccine protects against Zaire Ebola virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Pharmacokinetics study of a novel chimeric single-chain variable fragment antibody against western equine encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Pegylated alpha interferon is an effective treatment for virulent venezuelan equine encephalitis virus and has profound effects on the host immune response to infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Efficacy of DNA vaccination against western equine encephalitis virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Infectivity variation and genetic diversity among strains of Western equine encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Monoclonal antibody protects mice against infection and disease when given either before or up to 24 h after airborne challenge with virulent Venezuelan equine encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Aerosol exposure to western equine encephalitis virus causes fever and encephalitis in cynomolgus macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Recombinant chimeric western and eastern equine encephalitis viruses as potential vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Characterization of the murine alpha interferon gene family

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Expression of Coxsackie-Adenovirus receptor (CAR) in the developing mouse olfactory system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Construction and characterization of E3-deleted bovine adenovirus type 3 expressing full-length and truncated form of bovine herpesvirus type 1 glycoprotein gD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Adenovirus-mediated gene transfer in olfactory neurons in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.024

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2007.07.024

1 reference

Europe PubMed Central

30 November 2017

1 reference

Europe PubMed Central

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44137633&oldid=2107003253"